Jasper Therapeutics, Inc. (JSPR) Current Reports & Earnings Releases
Upcoming
- 2026-11-09 Earnings Release Estimated
| Filed | Form | Items | Filing |
|---|---|---|---|
| 2026-08-26 | 8-K | Material Agreement | SEC |
| 2026-08-14 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2026-08-03 | 8-K | Shareholder Vote Results | SEC |
| 2026-07-31 | 8-K | Other Events | SEC |
| 2026-07-17 | 8-K | Material Agreement, Acquisition or Disposition, Unregistered Sales, Officer / Director Changes, Charter Amendments, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2026-07-16 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2026-06-09 | 8-K | Listing Notice | SEC |
| 2026-06-01 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2026-05-21 | 8-K | Officer / Director Changes, Financial Statements & Exhibits | SEC |
| 2026-05-14 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2026-03-30 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2026-01-08 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2026-01-07 | 8-K | Officer / Director Changes, Other Events, Financial Statements & Exhibits | SEC |
| 2025-12-02 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2025-11-10 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-09-19 | 8-K | Material Agreement, Other Events, Financial Statements & Exhibits | SEC |
| 2025-08-13 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-07-09 | 8-K | Item 2.05, Officer / Director Changes, Other Events, Financial Statements & Exhibits | SEC |
| 2025-07-07 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2025-07-03 | 8-K | Shareholder Vote Results | SEC |
| 2025-06-16 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2025-05-12 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-03-19 | 8-K | Material Agreement, Termination of Agreement, Financial Statements & Exhibits | SEC |
| 2025-02-27 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-01-08 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2024-11-07 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-10-15 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2024-06-20 | 8-K | Officer / Director Changes, Other Events, Financial Statements & Exhibits | SEC |
| 2024-06-12 | 8-K | Officer / Director Changes, Shareholder Vote Results, Financial Statements & Exhibits | SEC |
| 2024-03-04 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-02-06 | 8-K | Material Agreement, Other Events, Financial Statements & Exhibits | SEC |
| 2024-01-04 | 8-K | Item 3.03, Charter Amendments, Financial Statements & Exhibits | SEC |
| 2024-01-02 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
Sourced from SEC EDGAR 8-K/6-K filings. 8-K is the current-report form for US domestic issuers (Item 2.02 = earnings release); 6-K is the equivalent for foreign private issuers, including ADRs. Originals live on sec.gov.